Cargando…
MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma
PURPOSE: Although promoter hypermethylation has been an accepted means of tumor suppressor gene inactivation, activation of otherwise normally repressed proto-oncogenes by promoter demethylation has been infrequently documented. EXPERIMENTAL DESIGN: In this study we performed an integrative, whole-g...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454438/ https://www.ncbi.nlm.nih.gov/pubmed/23029077 http://dx.doi.org/10.1371/journal.pone.0045534 |
_version_ | 1782244506274365440 |
---|---|
author | Pattani, Kavita M. Soudry, Ethan Glazer, Chad A. Ochs, Michael F. Wang, Hao Schussel, Juliana Sun, Wenyue Hennessey, Patrick Mydlarz, Wojciech Loyo, Myriam Demokan, Semra Smith, Ian M. Califano, Joseph A. |
author_facet | Pattani, Kavita M. Soudry, Ethan Glazer, Chad A. Ochs, Michael F. Wang, Hao Schussel, Juliana Sun, Wenyue Hennessey, Patrick Mydlarz, Wojciech Loyo, Myriam Demokan, Semra Smith, Ian M. Califano, Joseph A. |
author_sort | Pattani, Kavita M. |
collection | PubMed |
description | PURPOSE: Although promoter hypermethylation has been an accepted means of tumor suppressor gene inactivation, activation of otherwise normally repressed proto-oncogenes by promoter demethylation has been infrequently documented. EXPERIMENTAL DESIGN: In this study we performed an integrative, whole-genome analysis for discovery of epigenetically activated proto-oncogenes in head and neck cancer tumors. We used the 47K GeneChip U133 Plus 2.0 Affymetrix expression microarray platform to obtain re-expression data from 5-aza treated normal cell line and expression data from primary head and neck squamous cell carcinoma (HNSCC) tumor tissues and normal mucosa tissues. We then investigated candidate genes by screening promoter regions for CpG islands and bisulfite sequencing followed by QUMSP and RT PCR for the best candidate genes. Finally, functional studies were performed on the top candidate gene. RESULTS: From the top 178 screened candidates 96 had CpG islands in their promoter region. Seven candidate genes showed promoter region methylation in normal mucosa samples and promoter demethylation in a small cohort of primary HNSCC tissues. We then studied the demethylation of the top 3 candidate genes in an expanded cohort of 76 HNSCC tissue samples and 17 normal mucosa samples. We identified MAGEB2 as having significant promoter demethylation in primary head and neck squamous cell carcinoma tissues. We then found significantly higher expression of MAGEB2 in tumors in a separate cohort of 73 primary HNSCC tissues and 31 normal tissues. Finally, we found that MAGEB2 has growth promoting effects on minimally transformed oral keratinocyte cell lines but not a definite effect on HNSCC cell lines. CONCLUSION: In conclusion, we identified MAGEB2 as activated by promoter demethylation in HNSCCand demonstrates growth promoting effects in a minimally transformed oral keratinocyte cell line. More studies are needed to evaluate MAGBE2's exact role in HNSCC. |
format | Online Article Text |
id | pubmed-3454438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34544382012-10-01 MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma Pattani, Kavita M. Soudry, Ethan Glazer, Chad A. Ochs, Michael F. Wang, Hao Schussel, Juliana Sun, Wenyue Hennessey, Patrick Mydlarz, Wojciech Loyo, Myriam Demokan, Semra Smith, Ian M. Califano, Joseph A. PLoS One Research Article PURPOSE: Although promoter hypermethylation has been an accepted means of tumor suppressor gene inactivation, activation of otherwise normally repressed proto-oncogenes by promoter demethylation has been infrequently documented. EXPERIMENTAL DESIGN: In this study we performed an integrative, whole-genome analysis for discovery of epigenetically activated proto-oncogenes in head and neck cancer tumors. We used the 47K GeneChip U133 Plus 2.0 Affymetrix expression microarray platform to obtain re-expression data from 5-aza treated normal cell line and expression data from primary head and neck squamous cell carcinoma (HNSCC) tumor tissues and normal mucosa tissues. We then investigated candidate genes by screening promoter regions for CpG islands and bisulfite sequencing followed by QUMSP and RT PCR for the best candidate genes. Finally, functional studies were performed on the top candidate gene. RESULTS: From the top 178 screened candidates 96 had CpG islands in their promoter region. Seven candidate genes showed promoter region methylation in normal mucosa samples and promoter demethylation in a small cohort of primary HNSCC tissues. We then studied the demethylation of the top 3 candidate genes in an expanded cohort of 76 HNSCC tissue samples and 17 normal mucosa samples. We identified MAGEB2 as having significant promoter demethylation in primary head and neck squamous cell carcinoma tissues. We then found significantly higher expression of MAGEB2 in tumors in a separate cohort of 73 primary HNSCC tissues and 31 normal tissues. Finally, we found that MAGEB2 has growth promoting effects on minimally transformed oral keratinocyte cell lines but not a definite effect on HNSCC cell lines. CONCLUSION: In conclusion, we identified MAGEB2 as activated by promoter demethylation in HNSCCand demonstrates growth promoting effects in a minimally transformed oral keratinocyte cell line. More studies are needed to evaluate MAGBE2's exact role in HNSCC. Public Library of Science 2012-09-24 /pmc/articles/PMC3454438/ /pubmed/23029077 http://dx.doi.org/10.1371/journal.pone.0045534 Text en © 2012 Pattani et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Pattani, Kavita M. Soudry, Ethan Glazer, Chad A. Ochs, Michael F. Wang, Hao Schussel, Juliana Sun, Wenyue Hennessey, Patrick Mydlarz, Wojciech Loyo, Myriam Demokan, Semra Smith, Ian M. Califano, Joseph A. MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma |
title |
MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma |
title_full |
MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma |
title_fullStr |
MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma |
title_full_unstemmed |
MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma |
title_short |
MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma |
title_sort | mageb2 is activated by promoter demethylation in head and neck squamous cell carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454438/ https://www.ncbi.nlm.nih.gov/pubmed/23029077 http://dx.doi.org/10.1371/journal.pone.0045534 |
work_keys_str_mv | AT pattanikavitam mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT soudryethan mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT glazerchada mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT ochsmichaelf mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT wanghao mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT schusseljuliana mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT sunwenyue mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT hennesseypatrick mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT mydlarzwojciech mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT loyomyriam mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT demokansemra mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT smithianm mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma AT califanojosepha mageb2isactivatedbypromoterdemethylationinheadandnecksquamouscellcarcinoma |